These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date Terminated||2012-005146-38||"LANK-2": activated and expanded NK cell immunotherapy together with salvage chemotherapy in children, adolescents and young adults with relapsed or refractary acute leukemia||bad-data|
|Ongoing||2015-001901-15||Natural Killer cell infusion as consolidation therapy in children and adolescents with acute myelogenous leukemia.||not-yet-due|
|Exempt||2016-003578-42||Phase I / II Clinical Trial, multicenter, open, of infusion of activated NK cells for the treatment of children, adolescents and young adults with sarcomas.||not-yet-due|